Quick Answer
IONIS PHARMACEUTICALS INC reported Revenue (ASC 606) of $943.71 million for fiscal year 2025.
IONIS PHARMACEUTICALS INC Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $943.71M | +33.8% |
| 2024 | $705.14M | -10.5% |
| 2023 | $787.65M | +34.1% |
| 2022 | $587.37M | -27.5% |
| 2021 | $810.46M | +11.1% |
| 2020 | $729.26M | -35.0% |
| 2019 | $1.12B | +87.2% |
| 2018 | $599.67M | +16.6% |
| 2017 | $514.18M | +37.9% |
| 2016 | $372.78M | +308.7% |
| 2015 | $91.20M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $156.72M | +17.1% | -65.3% |
| June 30, 2025 | $452.05M | +100.7% | +243.5% |
| March 31, 2025 | $131.61M | +10.1% | -1.6% |
| September 30, 2024 | $133.81M | -7.2% | -40.6% |
| June 30, 2024 | $225.25M | +19.6% | +88.5% |
| March 31, 2024 | $119.50M | -8.4% | -17.1% |
| September 30, 2023 | $144.21M | -9.7% | -23.5% |
| June 30, 2023 | $188.41M | +40.8% | +44.3% |
- IONIS PHARMACEUTICALS INC showed an increase of +33.8% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2015–2025 period, IONIS PHARMACEUTICALS INC’s revenue (asc 606) has grown by 934.8% (from $91.20 million to $943.71 million).
- The most recent figure is from IONIS PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: